LiDCO Group plc (LID) – second profitable year for this exciting pharma company
LiDCO supplies minimally invasive and non-invasive hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO’s products enable the measurement, analysis, audit, training and sharing of real-time and historic hemodynamic data, in both critical care units and operating theatres.
Worldwide there are 240 million anaesthetic procedures performed per annum of which 24 million are high-risk surgeries. During the year a number of exciting studies that used LiDCO’s technology were published. These showed that LiDCO’s computer-based technology, developed at St Thomas’ Hospital in London, significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery such as high-risk cancer surgery, cardiac surgery and post-surgical intensive care populations. Today the Group announced audited Final Results for the year ended 31 January 2015. Despite a 4% reduction in revenue t0 8.27m (2013/14: £8.63), the Group delivered a second…